Mohammed Asmal looks forward to sharing the latest insight on #AI in clinical development as a panelist at the #CMO360Summit this week! Details below. Check out the full agenda from The Conference Forum here. https://lnkd.in/eiTf_uWN
Prime Medicine, Inc.
Biotechnology Research
Cambridge, Massachusetts 18,951 followers
Delivering on the promise of Prime Editing
About us
Prime Medicine was founded to bring the promise of gene editing to patients. We use Prime Editing, a next-generation technology that can “search and replace” to restore normal genetic function almost anywhere in the genome. Prime Editing searches to find the precise place in the genome to edit and replaces the segment of faulty DNA with a correct copy of DNA. A single Prime Editor can correct the individual mutations found across patients, meaning Prime Editing can potentially address more than 90 percent of known disease-causing genetic mutations. We envision a world where this technology can cure, halt, and ultimately prevent genetic diseases, providing lifelong benefit to patients. Prime Medicine offers the opportunity to shape the future of gene editing and transform how medicines are used to treat disease. Realizing the promise of Prime Editing requires a talented team with diversity of viewpoints and expertise. We’re building a group of dedicated, scientifically curious individuals who are passionate about helping patients live longer, healthier lives.
- Website
-
http://www.primemedicine.com
External link for Prime Medicine, Inc.
- Industry
- Biotechnology Research
- Company size
- 201-500 employees
- Headquarters
- Cambridge, Massachusetts
- Type
- Public Company
- Founded
- 2019
- Specialties
- Gene Editing
Locations
-
Primary
Get directions
60 First St
Cambridge, Massachusetts 02141, US
Employees at Prime Medicine, Inc.
Updates
-
To celebrate #WomensHistoryMonth, our Women@Prime + Allies group held a fireside chat with Prime board member Kaye Foster and speaker, author, and CEO of The Board Curators Daphne E. Jones. Her mentorship on equipping women leaders to take ownership of their careers was empowering, and the perfect way to celebrate the month. ♀️
-
-
Today, we unveiled a new program for the treatment of alpha-1 antitrypsin deficiency (#AATD), the second high-value program to emerge from our liver franchise. We expect to advance this program into the clinic next year. Learn more here. https://lnkd.in/eGNi-Xz4
-
-
Automation, including #AI, in the lab often offers greater scalability and increased accuracy, but it's critical to consider quality, ethics and complexity when incorporating it into daily tasks. Prime's Director of Plate-Based Analytical Assays and Head of Automation Rachael Cohen looks forward to sharing her expertise in #automation on this week's episode of Genetic Engineering & Biotechnology News Live. Register to listen to the event here. https://lnkd.in/gTPFR_QB
-
-
At a time when biotech business trends are uncertain and many patients are still waiting on new treatments, many may ask, where does #CRISPR go from here? Prime CEO Keith Gottesdiener looks forward to addressing this during the Endpoints News Catalysts event alongside other industry leaders this month. Register for the free, virtual event here. https://lnkd.in/g--qQNPg
-
-
Over 300M people across the globe are affected by a rare disease, and only 5% of those diseases have approved treatments. Prime is proud to be part of the community working to change that. This week, we recognized #RareDiseaseDay and honored patients & families by hosting a showing of Emmy-nominated documentary Rare in Common, sharing rare disease books and resources across offices, and wearing our stripes. 🦓
-
-
CSO Jeremy Duffield looks forward to participating in a panel during the Emily's Entourage Scientific Symposium in Philadelphia this week. Emily's Entourage works to accelerate research & drug development for people with #cysticfibrosis who don't benefit from mutation-targeted therapies. Learn more here. https://lnkd.in/gf-6v69X
-
-
We recently spent an afternoon volunteering at Cambridge's East End House in their Community Food Pantry. We helped distribute healthy food to more than 60 local families, saving them over $2,500 in grocery costs. We're proud to provide our team with meaningful opportunities to serve the community we live and work in.
-
-
We are proud to support this educational Coffee and Clinicians webinar hosted by the CGD Association of America on Advancing Transformative Therapies for CGD, featuring leading expert, Dr. Donald B. Kohn (UCLA). Registration details can be found via this link: https://bit.ly/42qzrLt
-